(TheNewswire) NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC TheNewswire – August 28, 2024 Heritage Mining Ltd. (CSE: HML FRA:Y66) (‘ Heritage ‘ or …
Investing
-
-
(TheNewswire) VANCOUVER, BC T he N ewswire August 28, 2024 Element79 Gold Corp. (CSE: ELEM) (OTC: ELMGF) (FSE: 7YS) (‘Element79’ the ‘Company ‘) today announced the addition of Mr. Warren Levy to the Board of …
-
2024 has been positive for silver stocks. A variety of factors pushed the white metal’s price higher during the second quarter, allowing it to break the US$30 per ounce mark for the first time since …
-
Investing
Blue Sky Uranium Announces Amendment to the Terms of the Non-Brokered Private Placement Using The Listed Issuer Financing Exemption
by admin/NOT FOR DISTRIBUTION TO UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ TSX Venture Exchange: BSK Frankfurt Stock Exchange: MAL2 Blue Sky Uranium Corp. (TSXV: BSK) (FSE: MAL2) (‘Blue Sky’ or the ‘Company’) announces …
-
All eyes in the investment world were on Nvidia (NASDAQ:NVDA) today (August 28) as the tech giant prepared to release its eagerly anticipated Q2 2025 earnings report after the closing bell. Amid growing concerns about …
-
Galan Lithium Limited (ASX:GLN) (Galan or the Company) is very pleased to announce that it has entered into an offtake prepayment memorandum of understanding with Chengdu Chemphys Chemical Industry Co., Ltd (Chemphys) in relation to …
-
-
Eskay Mining (TSXV:ESK,OTCQX:ESKYF) has wrapped up its summer exploration program, laying the foundation for a drill program in 2025 after opting to postpone drilling activities due to market conditions. “Because of the recent depressed market …
-
CleanTech Lithium PLC (AIM:CTL, Frankfurt:T2N, OTCQX:CTLHF) (‘the Company‘), an exploration and development company advancing lithium projects in Chile, refers to its previous announcement dated 13 August 2024, in respect of its application to dual-list on …
-
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical needs, is pleased to announce that it has increased its ownership stake …